636 related articles for article (PubMed ID: 23433467)
21. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
[TBL] [Abstract][Full Text] [Related]
22. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
Eisner BH; Eisenberg ML; Stoller ML
Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
[TBL] [Abstract][Full Text] [Related]
23. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
[TBL] [Abstract][Full Text] [Related]
24. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
25. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
26. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
[TBL] [Abstract][Full Text] [Related]
27. [Studies of urinary risk factors in urolithiasis].
Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
[TBL] [Abstract][Full Text] [Related]
28. Challenges in the diagnostic and therapeutic approach to nephrolithiasis.
McMahon GM; Seifter JL
Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):183-8. PubMed ID: 22257797
[TBL] [Abstract][Full Text] [Related]
29. Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
Hadian B; Zafar-Mohtashami A; Ghorbani F
Iran J Kidney Dis; 2018 Jan; 12(1):22-26. PubMed ID: 29421773
[TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome and urinary stone composition: what factors matter most?
Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
[TBL] [Abstract][Full Text] [Related]
31. Patients with primary hyperparathyroidism--why do some form stones?
Berger AD; Wu W; Eisner BH; Cooperberg MR; Duh QY; Stoller ML
J Urol; 2009 May; 181(5):2141-5. PubMed ID: 19296981
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
33. Clinical manifestations and etiology of renal stones in children less than 14 years age.
Sepahi MA; Heidari A; Shajari A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):181-4. PubMed ID: 20061721
[TBL] [Abstract][Full Text] [Related]
34. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
[TBL] [Abstract][Full Text] [Related]
35. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
[TBL] [Abstract][Full Text] [Related]
36. The growing prevalence of kidney stones and opportunities for prevention.
Richman K; O'Bell J; Pareek G
R I Med J (2013); 2014 Dec; 97(12):31-4. PubMed ID: 25463625
[TBL] [Abstract][Full Text] [Related]
37. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
[TBL] [Abstract][Full Text] [Related]
38. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
39. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
